Finance

Beta
Lists
RANI:NASDAQ
Rani Therapeutics Holdings Inc
$0.84
+1.22%
(+0.010) 1D
$0.82
-1.95% (-0.016)
After hours
Closed: Jun 8, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RANI...
Open
$0.84
High
$0.85
Low
$0.82
Mkt. cap
114.33M
Avg. vol.
1.01M
Volume
488.41K
52-wk high
$3.87
52-wk low
$0.39
EPS
-$0.41
Beta
0.74
Shares outstanding
99.91M
No. of employees
70
Open
$0.84
High
$0.85
Low
$0.82
Mkt. cap
114.33M
Avg. vol.
1.01M
Volume
488.41K
52-wk high
$3.87
52-wk low
$0.39
EPS
-$0.41
Beta
0.74
Shares outstanding
99.91M
No. of employees
70
Analyst outlook
Analyst Ratings
Based on 4 analysts giving stock ratings to RANI in the past 3 months
Strong Buy
Buy
4
Hold
0
Sell
0
12 month forecast
Based on 4 Wall Street analysts offering 12 month price targets for RANI in the last 3 months.
Highest
Current $0.84
$11.00 (+1,210.15%)
Average
$7.50 (+793.28%)
Lowest
$5.00 (+495.52%)
News stories
From sources across the web
About Rani Therapeutics Holdings Inc
CEO-
Employees70
Founded2012
HeadquartersSan Jose, California, United States
SectorPharmaceutical industry
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
1.46M
1.71M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
5.50M
3.22M
4.91M
5.16M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.00M
4.04M
5.09M
4.89M
Operating expense
10.50M
7.26M
10.00M
10.05M
Total operating expenses
10.50M
7.26M
10.00M
10.05M
Operating income
-10.50M
-7.26M
-8.54M
-8.34M
Other non operating income
-
-
-
-
EBT including unusual items
-11.22M
-7.91M
-9.07M
-8.02M
EBT excluding unusual items
-11.22M
-7.91M
-8.50M
-8.02M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-6.69M
-5.41M
-10.30M
-7.03M
Net profit margin
-
-
-705.34%
-411.77%
Earnings per share
-0.18
-0.12
-0.07
-0.04
Interest and investment income
158.00K
68.00K
384.00K
412.00K
Interest expense
-877.00K
-725.00K
-347.00K
-88.00K
Net interest expenses
-719.00K
-657.00K
37.00K
324.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-10.26M
-7.03M
-8.35M
-8.18M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more